Revenue: The sum of all revenue fields included for a company's operating activities.
Iovance Biotherapeutics, Inc. (IOVA) had Revenue of $1.19M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$1.19M |
$-444.04M |
|
$10.76M |
|
$-9.57M |
|
$461.75M |
|
$-460.56M |
|
$13.04M |
|
$-447.52M |
|
$-447.52M |
|
$-444.04M |
|
$-444.04M |
|
$-444.04M |
|
$-444.04M |
|
$-460.56M |
|
$-431.04M |
|
235.13M |
|
235.13M |
|
$-1.89 |
|
$-1.89 |
|
| Balance Sheet Financials | |
$307.85M |
|
$114.03M |
|
$472.50M |
|
$780.35M |
|
$110.31M |
|
$1.00M |
|
$85.43M |
|
$195.74M |
|
$584.61M |
|
$355.36M |
|
$584.61M |
|
256.14M |
|
| Cash Flow Statement Financials | |
$-361.82M |
|
$-155.24M |
|
$462.96M |
|
$238.16M |
|
$181.32M |
|
$-56.84M |
|
$62.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.79 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-804.54% |
|
-38734.98% |
|
-38734.98% |
|
-36252.06% |
|
-37638.01% |
|
-37345.42% |
|
$-384.11M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
1.04 |
|
7.87 |
|
46.35 |
|
-75.95% |
|
-124.96% |
|
-56.90% |
|
-75.82% |
|
$2.28 |
|
$-1.63 |
|
$-1.54 |
|